Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of the IL-6 Receptor: Effects On Hemoglobin Levels in a Clinical Trial for the Treatment of Moderate-to-Severe Rheumatoid Arthritis

Author(s):
Genovese, M.C.; Fleischmann, R.M.; Jasson, M.; Radin, A.R.; Hamilton, J.; Huizinga, T.W.J. (0000-0001-7033-7520)
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-10-31
Language
English
Is part of
Arthritis and Rheumatism (2012), Vol. 64, no. 10, p. S568-S568
hdl
1887/118434